Latest Strategic Investments News

Alligator Energy reports significant progress across its uranium portfolio, including regulatory milestones at Samphire and promising drilling results at Big Lake and Nabarlek North, supported by a solid cash position of $20.2 million.

Ragnar Metals advances its Swedish exploration with a significant spodumene pegmatite discovery at Orrvik and promising uranium assays at multiple new projects, while strengthening its strategic position through a key investment in Kaiser Reef.

Cambium Bio has secured a A$3 million capital raise and achieved FDA Fast Track status for its lead ophthalmology product, Elate Ocular®, setting the stage for Phase 3 trials in mid-2025.

Fatfish Group reported a 20% increase in cash receipts to A$0.76 million for Q4 2024, driven by advances in its AI gaming subsidiary, but rising operating expenses led to a net cash outflow of A$0.37 million.

Voltaic Strategic Resources reports significant gold and poly-metallic mineralisation at its Kooline and Meekatharra projects, alongside a strategic board restructure and a robust cash position of $5.4 million.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Althea Group Holdings reported a 20% increase in customer receipts to $9.01 million for Q2 FY25, while addressing governance lapses and reviewing its FY25 guidance. The company is advancing operational improvements and cost savings as it prepares for a pivotal Federal Court hearing.

Echelon Resources delivered a robust Q4 2024, driven by standout drilling results at Mereenie and a 23% rise in Amadeus production receipts, underpinning a strong financial position.

DigitalX Limited reported a 15% revenue increase in Q4 2024, driven by staking activities and performance fees, alongside a $10.3 million private placement and strategic Solana investment. The DigitalX Bitcoin ETF surpassed $50 million in funds under management, delivering a 67.4% quarterly return.

Tasman Resources has identified six promising drill targets at its Parkinson Dam gold project in South Australia, supported by advanced geophysical analysis and a new high-resolution gravity survey. The company also highlights ongoing investment in Eden Innovations and strategic funding moves.

IODM Limited reported a robust 49.4% increase in Q2 FY25 cash receipts, driven by explosive growth in its UK Education segment and strategic onboarding of prestigious universities.

Careteq Limited reports solid progress in integrating its Embedded Health Solutions with HMR Referrals, alongside a 14% revenue increase and improved cash flow in Q2 FY25.